US 12,246,081 B2
Deodorant compositions
Diana Sheila Cox, Bedford (GB); Alexander Gordon James, Higham Ferrers (GB); Mrinalini Jayant Puranik, Karnataka (IN); David William Thornthwaite, Little Neston (GB); and Jason Richard Williams, Wirral (GB)
Assigned to Conopco, Inc., Englewood Cliffs, NJ (US)
Appl. No. 16/769,518
Filed by Conopco, Inc., Englewood Cliffs, NJ (US)
PCT Filed Dec. 12, 2018, PCT No. PCT/EP2018/084639
§ 371(c)(1), (2) Date Jun. 3, 2020,
PCT Pub. No. WO2019/121269, PCT Pub. Date Jun. 27, 2019.
Claims priority of application No. 17209154 (EP), filed on Dec. 20, 2017.
Prior Publication US 2020/0383891 A1, Dec. 10, 2020
Int. Cl. A61K 8/49 (2006.01); A61K 8/66 (2006.01); A61Q 15/00 (2006.01)
CPC A61K 8/49 (2013.01) [A61K 8/66 (2013.01); A61Q 15/00 (2013.01); A61K 2800/59 (2013.01); A61K 2800/78 (2013.01)] 9 Claims
 
1. A human deodorant composition comprising:
(1) an oxazolidine-carboxylic acid compound; and
(2) a cosmetic carrier;
wherein the oxazolidine-carboxylic acid compound is:
(i) a compound of formula (I);
(ii) an ester of a compound of formula (I);
(iii) a salt of a compound of formula (I); or
(iv) a compound that releases a compound of formula (I) in use;

OG Complex Work Unit Chemistry
wherein X is O;
wherein R1, R2 and R3 are same or different group;
wherein R1 is hydrogen, C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, C3-C20 alkenyl, C3-C20 aryl residue, or mixtures thereof;
wherein R2 and R3 are each independently C3-C20 linear alkyl, C3-C20 branched alkyl, C3-C20 cyclic alkyl, C3-C20 alkenyl, C3-C20 aryl residue, mixtures thereof, or linked to form a cyclic structure;
wherein the deodorant composition is a topical deodorant composition; and wherein the cosmetic carrier comprise a water-insoluble organic material.